- Presentations
- 3
- Markets
- 1
Arnuity Ellipta is a brand of Fluticasone furoate marketed by GlaxoSmithKline, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Fluticasone furoate
- Brand owner
- GlaxoSmithKline
- Registered in
- United States
- Strengths and forms
- 100 mcg inhalation powder, 200 mcg inhalation powder, 50 mcg inhalation powder
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Arnuity Ellipta 100 mcg inhalation powderInhalation | GlaxoSmithKline | US FDA | Available on request |
| Arnuity Ellipta 200 mcg inhalation powderInhalation | GlaxoSmithKline | US FDA | Available on request |
| Arnuity Ellipta 50 mcg inhalation powderInhalation | GlaxoSmithKline | US FDA | Available on request |
Equivalent brands
Other brands of Fluticasone furoate.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Arnuity Ellipta
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.